logo

Sanofi (SNYNF)



Trade SNYNF now with
  Date
  Headline
5/22/2018 8:04:26 AM Sanofi Says FDA To Review Zynquista As Potential Treatment For Type 1 Diabetes
5/22/2018 8:01:47 AM Sanofi: FDA To Review Zynquista (sotagliflozin) As Potential Treatment For Type 1 Diabetes
5/16/2018 1:02:42 AM Regeneron, Sanofi: Pivotal Phase 3 Trial Evaluating DUPIXENT Met Its Primary And Key Secondary Endpoints
5/14/2018 2:07:42 AM Sanofi Announces Successful Results Of Initial Tender Offer Period For Ablynx
5/1/2018 7:04:26 AM Sanofi And Regeneron To Lower Net Price Of Praluent Injection
4/30/2018 1:03:02 AM Regeneron, Sanofi: FDA To Conduct Priority Review Of Cemiplimab As Potential Treatment For Advanced CSCC
4/27/2018 1:34:27 AM Sanofi Q1 Business EPS EUR 1.28, Up 1.4% At CER
4/25/2018 9:09:52 AM Sanofi: FDA Accepts For Review SbLA For 0.5 ML Dose Of Fluzone Quadrivalent In Children 6-35 Months Of Age
4/25/2018 5:22:30 AM Boehringer Expects A Slight Sales Growth For The Current Year
4/24/2018 1:32:12 AM Sanofi Head Of Global R&D Elias Zerhouni To Retire; Names John Reed To Take Over On July 1